메뉴 건너뛰기




Volumn 5, Issue 5, 2007, Pages 1068-1070

A case of profound and prolonged tirofiban-induced thrombocytopenia and its correction by intravenous immunoglobulin G [3]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CORTICOSTEROID; ENOXAPARIN; HEMOGLOBIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE SODIUM SUCCINATE; PROTEIN ANTIBODY; TIROFIBAN;

EID: 34247877840     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02440.x     Document Type: Letter
Times cited : (14)

References (12)
  • 1
    • 0033573790 scopus 로고    scopus 로고
    • Platelet GPIIb-IIIa blockers
    • Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet 1999; 353: 227-31.
    • (1999) Lancet , vol.353 , pp. 227-231
    • Topol, E.J.1    Byzova, T.V.2    Plow, E.F.3
  • 3
    • 33646016570 scopus 로고    scopus 로고
    • The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: Position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors
    • Aster RH, Curtis BR, Bougie DW, Dunkley S, Greinacher A, Warkentin TE, Chong BH. The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: Position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. J Thromb Haemost 2006; 4: 678-9.
    • (2006) J Thromb Haemost , vol.4 , pp. 678-679
    • Aster, R.H.1    Curtis, B.R.2    Bougie, D.W.3    Dunkley, S.4    Greinacher, A.5    Warkentin, T.E.6    Chong, B.H.7
  • 4
    • 0037105428 scopus 로고    scopus 로고
    • Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa
    • Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J, Aster RH. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 2002; 100: 2071-6.
    • (2002) Blood , vol.100 , pp. 2071-2076
    • Bougie, D.W.1    Wilker, P.R.2    Wuitschick, E.D.3    Curtis, B.R.4    Malik, M.5    Levine, S.6    Lind, R.N.7    Pereira, J.8    Aster, R.H.9
  • 6
    • 2442570825 scopus 로고    scopus 로고
    • Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting
    • Merlini PA, Rossi M, Menozzi A, Buratti S, Brennan DM, Moliterno DJ, Topol EJ, Ardissino D. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Circulation 2004; 109: 2203-6.
    • (2004) Circulation , vol.109 , pp. 2203-2206
    • Merlini, P.A.1    Rossi, M.2    Menozzi, A.3    Buratti, S.4    Brennan, D.M.5    Moliterno, D.J.6    Topol, E.J.7    Ardissino, D.8
  • 8
    • 6344274868 scopus 로고    scopus 로고
    • Delayed thrombocytopenia after treatment with abciximab: A distinct clinical entity associated with the immune response to the drug
    • Curtis BR, Divgi A, Garrity T, Aster RH. Delayed thrombocytopenia after treatment with abciximab: A distinct clinical entity associated with the immune response to the drug. J Thromb Haemost 2004; 2: 985-92.
    • (2004) J Thromb Haemost , vol.2 , pp. 985-992
    • Curtis, B.R.1    Divgi, A.2    Garrity, T.3    Aster, R.H.4
  • 9
    • 23844531640 scopus 로고    scopus 로고
    • Delayed tirofiban-induced thrombocytopenia: Two case reports
    • Bosco A, Kidson-Gerber G, Dunkley S. Delayed tirofiban-induced thrombocytopenia: Two case reports. J Thromb Haemost 2005; 3: 1109-10.
    • (2005) J Thromb Haemost , vol.3 , pp. 1109-1110
    • Bosco, A.1    Kidson-Gerber, G.2    Dunkley, S.3
  • 10
    • 30944449768 scopus 로고    scopus 로고
    • Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events
    • Dunkley S, Evans S, Gaudry L, Jepson N. Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events. Platelets 2005; 16: 462-8.
    • (2005) Platelets , vol.16 , pp. 462-468
    • Dunkley, S.1    Evans, S.2    Gaudry, L.3    Jepson, N.4
  • 11
    • 33746638332 scopus 로고    scopus 로고
    • Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by anti-platelet GPIIb-IIIa vs. GPIbα antibodies
    • Webster ML, Sayeh E, Crow M, Chen P, Nieswandt B, Freedman J, Ni H. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by anti-platelet GPIIb-IIIa vs. GPIbα antibodies. Blood 2006; 108: 943-6.
    • (2006) Blood , vol.108 , pp. 943-946
    • Webster, M.L.1    Sayeh, E.2    Crow, M.3    Chen, P.4    Nieswandt, B.5    Freedman, J.6    Ni, H.7
  • 12
    • 33644701024 scopus 로고    scopus 로고
    • Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia
    • Dorsch MP, Montague D, Rodgers JE, Patterson C. Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia. Pharmacotherapy 2006; 26: 423-7.
    • (2006) Pharmacotherapy , vol.26 , pp. 423-427
    • Dorsch, M.P.1    Montague, D.2    Rodgers, J.E.3    Patterson, C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.